Baxter to sell its kidney-care business in a $3.8 billion deal to Carlyle Group

By / / Finance / 1 minute of reading




Shares of Baxter International Inc. gained ground early Tuesday, after the healthcare-products company announced an agreement to sell its kidney-care business — to be named Vantive — to private-equity investor Carlyle Group Inc. in a deal valued at $3.8 billion.



Source link

About The Author

Avatar of Lisa Ferguson
Lisa Ferguson is an award-winning writer and editor who is passionate about politics, health, business, and finance. In her free time, Lisa loves to read nonfiction books and watch documentaries about current affairs. Her favorite subjects are health care policy, climate change, and social justice issues like immigration reform.

Start typing and press enter to search

Scroll to Top